Date

2022-07-20

Protocol

Protocol changed

Item Changed

1. Funding source 2. Primary study sponsor/organization

Previous Version

1. Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404, USA 2. Gilead Sciences, Inc, Gilead Clinical Study Information Center 333 Lakeside Drive Foster City, CA 94404, USA, +1-833-445-3230, GileadClinicalTrials@gilead.com

Next Version

1. Galapagos NV, Generaal De Wittelaan L11 A3, 2800, Mechelen, Belgium 2. Galapagos NV, Generaal De Wittelaan L11 A3, 2800, Mechelen, Belgium, +32 15 342 900